{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:14:06Z","timestamp":1785212046233,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:00:00Z","timestamp":1621555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:00:00Z","timestamp":1621555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To evaluate national epidemiologic data on infants treated for patent ductus arteriosus (PDA) in Korea and analyze outcomes associated with different PDA treatments. We retrospectively evaluated data on 12,336 patients diagnosed with PDA (International Classification of Diseases-10 code: Q250) between 2015 and 2018 from the Health Insurance Review and Assessment database. Among them, 1623 patients underwent surgical ligation (code: O1671). We used birth certificate data from Statistics Korea to estimate the prevalence, diagnosis, and treatment of PDA. The prevalence of infants with PDA was 81 infants per 10,000 live births and 45.2% in very low birth weight (VLBW) infants, which increased from 2015 to 2018. PDA ligation was performed in 2571 infants and 22% VLBW infants. Medical treatment was administered to 4202 infants, which decreased significantly, especially in VLBW infants (62% to 53%). The proportion of treatment was as follows: conservative treatment (53.1%), intravenous ibuprofen (24.4%), surgery (20.4%), and oral ibuprofen (10.7%); that among 4854 VLBW infants was as follows: intravenous ibuprofen (46.3%), conservative treatment (33.2%), surgery (22.2%), and oral ibuprofen (14.2%). Surgical treatment had a significantly higher risk (odds ratio 1.36) of mortality than conservative treatment. Surgical and\/or medical treatments were associated with a higher risk of morbidity. Recently, increased use of conservative management of PDA has contributed to improved neonatal outcomes in VLBW infants. Select patients may still benefit from surgical ligation following careful consideration.\n<\/jats:p>","DOI":"10.1038\/s41598-021-89868-z","type":"journal-article","created":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T10:02:50Z","timestamp":1621591370000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Patent ductus arteriosus treatment trends and associated morbidities in neonates"],"prefix":"10.1038","volume":"11","author":[{"given":"Joonsik","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So J","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungho","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In G","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joohee","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong E","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho S","family":"Eun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kook I","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min S","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon M","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,21]]},"reference":[{"key":"89868_CR1","doi-asserted-by":"publisher","first-page":"F505","DOI":"10.1136\/archdischild-2013-303816","volume":"98","author":"A Sellmer","year":"2013","unstructured":"Sellmer, A. et al. Morbidity and mortality in preterm neonates with patent ductus arteriosus on day 3. Arch. Dis. Child. Fetal Neonatal. Ed. 98, F505\u2013F510 (2013).","journal-title":"Arch. Dis. Child. Fetal Neonatal. Ed."},{"key":"89868_CR2","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1542\/peds.2009-3506","volume":"125","author":"SE Hamrick","year":"2010","unstructured":"Hamrick, S. E. & Hansmann, G. Patent ductus arteriosus of the preterm infant. Pediatrics 125, 1020\u20131030 (2010).","journal-title":"Pediatrics"},{"key":"89868_CR3","doi-asserted-by":"crossref","unstructured":"Malviya MN, Ohlsson A, Shah SS. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev. Cd003951 (2013)","DOI":"10.1002\/14651858.CD003951.pub3"},{"key":"89868_CR4","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.jpeds.2012.05.007","volume":"161","author":"L Mirea","year":"2012","unstructured":"Mirea, L. et al. Treatment of patent ductus arteriosus and neonatal mortality\/morbidities: adjustment for treatment selection bias. J. Pediatr. 161, 689\u2013694 (2012).","journal-title":"J. Pediatr."},{"key":"89868_CR5","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.jpeds.2009.01.005","volume":"154","author":"R Clyman","year":"2009","unstructured":"Clyman, R., Cassady, G., Kirklin, J. K., Collins, M. & Philips, J. B. III. The role of patent ductus arteriosus ligation in bronchopulmonary dysplasia: reexamining a randomized controlled trial. J. Pediatr. 154, 873\u2013876 (2009).","journal-title":"J. Pediatr."},{"key":"89868_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jpeds.2006.11.039","volume":"150","author":"NS Kabra","year":"2007","unstructured":"Kabra, N. S. et al. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J. Pediatr. 150, 229\u2013234 (2007).","journal-title":"J. Pediatr."},{"key":"89868_CR7","doi-asserted-by":"crossref","unstructured":"Madan JC, Kendrick D, Hagadorn JI, Frantz ID, 3rd, National Institute of Child H, Human Development Neonatal Research N. Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome. Pediatrics. 123, 674\u201381 (2009)","DOI":"10.1542\/peds.2007-2781"},{"key":"89868_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4103\/2249-4847.134670","volume":"3","author":"DE Weisz","year":"2014","unstructured":"Weisz, D. E. & McNamara, P. J. Patent ductus arteriosus ligation and adverse outcomes: causality or bias?. J. Clin. Neonatol. 3, 67\u201375 (2014).","journal-title":"J. Clin. Neonatol."},{"key":"89868_CR9","doi-asserted-by":"publisher","first-page":"e1024","DOI":"10.1542\/peds.2013-3431","volume":"133","author":"DE Weisz","year":"2014","unstructured":"Weisz, D. E., More, K., McNamara, P. J. & Shah, P. S. PDA ligation and health outcomes: a meta-analysis. Pediatrics 133, e1024\u2013e1046 (2014).","journal-title":"Pediatrics"},{"key":"89868_CR10","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.siny.2018.03.003","volume":"23","author":"DE Weisz","year":"2018","unstructured":"Weisz, D. E. & Giesinger, R. E. Surgical management of a patent ductus arteriosus: Is this still an option?. Semin. Fetal. Neonatal. Med. 23, 255\u2013266 (2018).","journal-title":"Semin. Fetal. Neonatal. Med."},{"key":"89868_CR11","doi-asserted-by":"publisher","first-page":"F498","DOI":"10.1136\/adc.2005.092734","volume":"92","author":"CL Bose","year":"2007","unstructured":"Bose, C. L. & Laughon, M. M. Patent ductus arteriosus: lack of evidence for common treatments. Arch. Dis. Child Fetal. Neonatal. Ed. 92, F498-502 (2007).","journal-title":"Arch. Dis. Child Fetal. Neonatal. Ed."},{"key":"89868_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006181.pub2:Cd006181","author":"R Mosalli","year":"2008","unstructured":"Mosalli, R. & Alfaleh, K. Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity in extremely low birth weight infants. Cochrane Database Syst. Rev. https:\/\/doi.org\/10.1002\/14651858.CD006181.pub2:Cd006181 (2008).","journal-title":"Cochrane Database Syst. Rev."},{"key":"89868_CR13","doi-asserted-by":"publisher","first-page":"e0212256","DOI":"10.1371\/journal.pone.0212256","volume":"14","author":"SI Sung","year":"2019","unstructured":"Sung, S. I. et al. Natural evolution of ductus arteriosus with noninterventional conservative management in extremely preterm infants born at 23\u201328 weeks of gestation. PLoS ONE 14, e0212256 (2019).","journal-title":"PLoS ONE"},{"key":"89868_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jpeds.2016.06.046","volume":"177","author":"SI Sung","year":"2016","unstructured":"Sung, S. I. et al. Mandatory closure versus nonintervention for patent ductus arteriosus in very preterm infants. J. Pediatr. 177, 66\u201371 (2016).","journal-title":"J. Pediatr."},{"key":"89868_CR15","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/jp.2017.4","volume":"37","author":"MA Mohamed","year":"2017","unstructured":"Mohamed, M. A. et al. Patent ductus arteriosus in premature infants: to treat or not to treat?. J. Perinatol. 37, 652\u2013657 (2017).","journal-title":"J. Perinatol."},{"key":"89868_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jpeds.2018.09.012","volume":"205","author":"RI Clyman","year":"2019","unstructured":"Clyman, R. I. et al. PDA-TOLERATE trial: an exploratory randomized controlled trial of treatment of moderate-to-large patent ductus arteriosus at 1 week of age. J. Pediatr. 205, 41\u201348 (2019).","journal-title":"J. Pediatr."},{"key":"89868_CR17","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1001\/jamapediatrics.2020.1447","volume":"174","author":"SI Sung","year":"2020","unstructured":"Sung, S. I., Lee, M. H., Ahn, S. Y., Chang, Y. S. & Park, W. S. Effect of nonintervention vs oral ibuprofen in patent ductus arteriosus in preterm infants: a randomized clinical trial. JAMA Pediatr. 174, 755\u2013763 (2020).","journal-title":"JAMA Pediatr."},{"key":"89868_CR18","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/pr.2016.166","volume":"80","author":"JI Hagadorn","year":"2016","unstructured":"Hagadorn, J. I. et al. Trends and variation in management and outcomes of very low-birth-weight infants with patent ductus arteriosus. Pediatr Res. 80, 785\u2013792 (2016).","journal-title":"Pediatr Res."},{"key":"89868_CR19","doi-asserted-by":"crossref","unstructured":"Ngo S, Profit J, Gould JB, Lee HC. Trends in Patent Ductus Arteriosus Diagnosis and Management for Very Low Birth Weight Infants. Pediatrics. 139 (2017)","DOI":"10.1542\/peds.2016-2390"},{"key":"89868_CR20","doi-asserted-by":"publisher","first-page":"e2014008","DOI":"10.4178\/epih\/e2014008","volume":"36","author":"L Kim","year":"2014","unstructured":"Kim, L., Kim, J. A. & Kim, S. A guide for the utilization of health insurance review and assessment service national patient samples. Epidemiol. Health. 36, e2014008 (2014).","journal-title":"Epidemiol. Health."},{"key":"89868_CR21","doi-asserted-by":"crossref","unstructured":"The Vermont-Oxford Trials Network: very low birth weight outcomes for 1990. Investigators of the Vermont-Oxford Trials Network Database Project. Pediatrics. 91, 540\u20135 (1993)","DOI":"10.1542\/peds.91.3.540"},{"key":"89868_CR22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.pedneo.2020.03.009","volume":"61","author":"HF Othman","year":"2020","unstructured":"Othman, H. F., Linfield, D. T., Mohamed, M. A. & Aly, H. Ligation of patent ductus arteriosus in very low birth weight premature infants. Pediatr Neonatol. 61, 399\u2013405 (2020).","journal-title":"Pediatr Neonatol."},{"issue":"Suppl 1","key":"89868_CR23","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.3346\/jkms.2015.30.S1.S59","volume":"30","author":"JA Lee","year":"2015","unstructured":"Lee, J. A., Kim, M. J., Oh, S. & Choi, B. M. Current status of therapeutic strategies for patent ductus arteriosus in very-low-birth-weight infants in Korea. J. Korean. Med. Sci. 30(Suppl 1), S59-66 (2015).","journal-title":"J. Korean. Med. Sci."},{"key":"89868_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1542\/peds.2020-1209","volume":"1","author":"SEG Hamrick","year":"2020","unstructured":"Hamrick, S. E. G. et al. Patent ductus arteriosus of the preterm infant. Pediatrics 1, 1. https:\/\/doi.org\/10.1542\/peds.2020-1209 (2020).","journal-title":"Pediatrics"},{"key":"89868_CR25","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1542\/peds.2005-1528","volume":"117","author":"J Koch","year":"2006","unstructured":"Koch, J. et al. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics 117, 1113\u20131121 (2006).","journal-title":"Pediatrics"},{"key":"89868_CR26","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1001\/jama.2018.1896","volume":"319","author":"S Mitra","year":"2018","unstructured":"Mitra, S. et al. Association of placebo, indomethacin, ibuprofen, and acetaminophen with closure of hemodynamically significant patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. JAMA 319, 1221\u20131238 (2018).","journal-title":"JAMA"},{"key":"89868_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-2431-6-15","volume":"6","author":"LC Lee","year":"2006","unstructured":"Lee, L. C., Tillett, A., Tulloh, R., Yates, R. & Kelsall, W. Outcome following patent ductus arteriosus ligation in premature infants: a retrospective cohort analysis. BMC Pediatr. 6, 15 (2006).","journal-title":"BMC Pediatr."},{"key":"89868_CR28","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3349\/ymj.2008.49.2.265","volume":"49","author":"GY Lee","year":"2008","unstructured":"Lee, G. Y. et al. Outcome following surgical closure of patent ductus arteriosus in very low birth weight infants in neonatal intensive care unit. Yonsei. Med. J. 49, 265\u2013271 (2008).","journal-title":"Yonsei. Med. J."},{"key":"89868_CR29","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13019-020-01191-2","volume":"15","author":"JH Lee","year":"2020","unstructured":"Lee, J. H. et al. Surgical ligation of patent ductus arteriosus in preterm neonates weighing less than 1500g: a 9-year single center experience. J. Cardiothorac. Surg. 15, 144 (2020).","journal-title":"J. Cardiothorac. Surg."},{"issue":"5","key":"89868_CR30","doi-asserted-by":"publisher","first-page":"e20182565","DOI":"10.1542\/peds.2018-2565","volume":"143","author":"J Kumar","year":"2019","unstructured":"Kumar J, Dutta S, Sundaram V, Saini SS, Sharma RR, Varma N. Platelet Transfusion for PDA Closure in Preterm Infants: A\nRandomized Controlled Trial. Pediatrics 143(5), e20182565. https:\/\/doi.org\/10.1542\/peds.2018-2565 (2019).","journal-title":"Pediatrics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89868-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89868-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89868-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T08:38:02Z","timestamp":1670056682000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89868-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,21]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["89868"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-89868-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,21]]},"assertion":[{"value":"30 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10689"}}